Skip to main content

Vivos Therapeutics, Inc.

corporate_fare Company Profile

Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Exchange: NASDAQSector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed VVOS - Latest Insights

VVOS
Apr 22, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
9
VVOS
Apr 15, 2026, 5:05 PM EDT
Source: Wiseek News
Importance Score:
9
VVOS
Apr 15, 2026, 5:00 PM EDT
Filing Type: 10-K
Importance Score:
9
VVOS
Apr 03, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
VVOS
Apr 02, 2026, 7:34 PM EDT
Filing Type: 4
Importance Score:
9
VVOS
Apr 02, 2026, 6:32 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
VVOS
Mar 26, 2026, 8:45 AM EDT
Source: GlobeNewswire
Importance Score:
9
VVOS
Feb 13, 2026, 7:17 PM EST
Filing Type: S-3
Importance Score:
7
VVOS
Jan 20, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
VVOS
Jan 16, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
VVOS
Jan 14, 2026, 4:05 PM EST
Filing Type: 424B3
Importance Score:
8